Sexual Enhancers Global Market Overview 2024
03 oct. 2024 10h10 HE
|
Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The "Sexual Enhancers - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Sexual Enhancers is...
U.S. Contraceptive Market Report 2024-2030: Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectables Size, Share & Trends Analysis
19 sept. 2024 10h43 HE
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal...
OC/LEP (Oral Contraception, Low Dose Estrogen Progestin) Market Research 2024 Featuring Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer, Merck, Teva, Abbvie, Viatris, and Cipla
12 sept. 2024 09h55 HE
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By...
Emergency Contraceptive Pills Market: North America Leads with Promising Growth Opportunities and Outlook to 2031
31 janv. 2024 10h31 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Emergency Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Femtech Market Predicted to Surge, Fuelled by Technological Advances and Women-Centric Health Solutions
15 janv. 2024 12h23 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Femtech Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering. The latest comprehensive research...
Progestin Options Set to Dominate Contraceptive Pills Market: Insights from 2023 to 2030
25 sept. 2023 07h28 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Global Contraceptive Pills Market by Hormone Type (Combination Pills, Progestin Pills), Category (Branded, Generic) - Cumulative Impact of COVID-19,...
Global Femtech Market Report (2022 to 2028) - Players Include Google, HeraMED, iSono Health and Chiaro Technology
11 juil. 2022 05h18 HE
|
Research and Markets
Dublin, July 11, 2022 (GLOBE NEWSWIRE) -- The "Global Femtech Market Size, Share & Industry Trends Analysis Report By Product Type, By Mobile Apps Type, By Regional Outlook and Forecast, 2022 -...
Agile Therapeutics Reports Third Quarter 2017 Financial Results
06 nov. 2017 16h20 HE
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations into Q2 2018 Prescription Drug User Fee Act (PDUFA) Goal Date for Twirla® is December 26, 2017 PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile...
Agile Therapeutics to Host First Analyst Day on October 10, 2017
02 oct. 2017 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...
Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine
07 sept. 2017 07h50 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract presenting data from the Phase 3 SECURE...